BERNARDI, MAURO

BERNARDI, MAURO  

Mostra records
Risultati 1 - 20 di 90 (tempo di esecuzione: 0.047 secondi).
Titolo Data di pubblicazione Autore(i) File
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis 1-gen-2015 Biselli, M; Conti, F; Gramenzi, A; Frigerio, M; Cucchetti, A; Fatti, A; D'Angelo, M; Dall'Agata, M; Giannini, Eg; Farinati, F; Ciccarese, F; Andreone, P; Bernardi, M; Trevisani, F.
A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of non-responder patients with chronic hepatitic C 1-gen-2007 Gramenzi, A; Andreone, P; Cursaro, C; Verucchi, G; Boccia, S; Giacomoni, Pl; Galli, S; Furlini, G; Biselli, M; Lorenzini, S; Attard, L; Bonvicini, F; Bernardi, M.
Acquired intestinal lymphangiectasia successfully treated with a low fat and MCT-enriched diet in a patient with liver transplantation 1-gen-2006 Biselli, Maurizio; Andreone, Pietro; Gramenzi, Annagiulia; Cursaro, C; Lorenzini, S; Bonvicini, Fiorenza; Bernardi, Mauro
Adaptive response in Hepatitis B virus infection 1-gen-2014 Loggi, E.; Gamal, N.; Bihl, F.; Bernardi, M.; Andreone, P.
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions 1-gen-2017 Lonardo, Amedeo; Nascimbeni, Fabio; Targher, Giovanni; Bernardi, Mauro; Bonino, Ferruccio; Bugianesi, Elisabetta; Casini, Alessandro; Gastaldelli, Amalia; Marchesini, Giulio; Marra, Fabio; Miele, Luca; Morisco, Filomena; Petta, Salvatore; Piscaglia, Fabio; Svegliati-Baroni, Gianluca; Valenti, Luca; Bellentani, Stefano
Alcohol and viral hepatitis: a mini-review 1-gen-2009 Gitto, S; Micco, L; Conti, F; Andreone, P; Bernardi, M.
Alcoholic liver disease: pathophisiological aspects and risk factors. A review 1-gen-2006 Gramenzi, Annagiulia; Caputo, Fabio; Biselli, Maurizio; Kuria, F; Loggi, Elisabetta; Andreone, Pietro; Bernardi, Mauro
Allocation priority in non urgent liver transplantation: an overview of proposed scoring systems 1-gen-2009 Gitto, S; Lorenzini, S; Biselli, M; Conti, F; Andreone, P; Bernardi, M.
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report 1-gen-2014 Gamal, N; Brodosi, L; Misciali, C; Patrizi, A; Vukatana, G; Malavolta, N; Bernardi, M; Andreone, P.
An in-depth psychosocial and biochemical evaluation in transplant recipients for alcoholic liver disease should be planned 1-gen-2010 Gitto, S; Biselli, M; Bernardi, M; Andreone, P.
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 1-gen-2009 Loggi, Elisabetta; Bihl, F; Chisolm JV, 3rd; Biselli, Maurizio; Bontadini, A; Vitale, G; Ercolani, Giorgio; Grazi, GIAN LUCA; Pinna, ANTONIO DANIELE; Bernardi, Mauro; Brander, C; Andreone, Pietro
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C 1-gen-2012 Loggi, Elisabetta; Scuteri, Alessandra; MARTELLO PANNO, Arianna; Grandini, Elena; Cursaro, C.; Margotti, Marzia; Foglianti, G.; Bernardi, Mauro; Brillanti, Stefano; Andreone, Pietro
Bone marrow derived stem cells for the treatment of end-stage liver disease 1-gen-2014 Margini, C; Vukotic, R; Brodosi, L; Bernardi, M; Andreone, P.
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma 1-gen-2009 Magini, Giulia; Farsad, M; Frigerio, Marta; Serra, C; Colecchia, Antonio; Jovine, E; Vivarelli, Marco; Feletti, Valentina; Golfieri, R; Patti, C; Fanti, Stefano; Franchi, Roberto; Lodi, F; Boschi, S; Bernardi, Mauro; Trevisani, Franco
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients 1-gen-2014 Vukotic, Ranka; Morelli, M; Pinna, Antonio Daniele; Margotti, Marzia; Foschi, Fg; Loggi, Elisabetta; Bernardi, Mauro; Andreone, Pietro
CD 133+ stem cells for the treatment of end stage liver disease 1-gen-2012 Brodosi, Lucia; Catani, Lucia; S., Lorenzini; R., Giordano; S., Rizzi; V., Giudice; Sollazzo, Daria; B., Nicolini; E., Montelatici; T., Montemurro; E., Dan; E., Massari; Baccarani, Michele; Bernardi, Mauro; Lemoli, ROBERTO MASSIMO; Andreone, Pietro
Characterization of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver 1-gen-2010 Lorenzini, S; Bird, Tg; Clayton, E; Bellamy, C; Samuel, K; Aucott, R; Andreone, P; Bernardi, M; Golding, M; Alison, Mr; Iredale, Jp; Forbes, Sj.
Chronic hepatitis B: Are we close to a cure? 1-gen-2015 E, Loggi; Vitale, Giovanni; Conti, Fabio; Bernardi, Mauro; Andreone, Pietro
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 1-gen-2008 Lodato, F; Berardi, S; Gramenzi, A; Mazzella, G; Lenzi, M; Morelli, Mc; Tame, Mr; Piscaglia, F; Andreone, P; Bologna Liver Transplantation Group (BLTG), [. . .; Ballardini, G; Bernardi, M; Bianchi, Fb; Biselli, M; Bolondi, L; Cescon, M; Colecchia, A; D'Errico, A; Del Gaudio, M; Ercolani, G; Grazi, Gl; Grigioni, W; Lorenzini, S; Pinna, Ad; Ravaioli, M; Roda, E; Sama, C; Vivarelli, M.; ], . .
Comparing and combining gamma-hydroxybutiric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomized comparative study 1-gen-2007 Caputo, Fabio; Addolorato, G; Stoppo, M; Francini, S; Vignoli, Teo; Lorenzini, F; Del Re, A; Comaschi, C; Andreone, Pietro; Trevisani, Franco; Bernardi, Mauro